Immunocytochemical Evaluation of Estrogen Receptor on Archival Papanicolaou-Stained Fine-Needle Aspirate Smears

Diagnostic Cytopathology

Volumn 29, Issue 6, 2003, Pages 309-314

  Krishnamurthy, Savitri ^a,c   Dimashkieh, Haytham ^b   Patel, Shobha ^a   Sneige, Nour ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Estrogen receptor; Fine needle aspiration; Immunocytochemistry

Indexed keywords

ACETONE; ESTROGEN RECEPTOR; FORMALDEHYDE; METHANOL; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY H222; MONOCLONAL ANTIBODY ID5; UNCLASSIFIED DRUG;

ARTICLE; ASPIRATION BIOPSY; BREAST CARCINOMA; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; EVALUATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; KAPPA STATISTICS; PAPANICOLAOU TEST; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELIABILITY; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TISSUE FIXATION; TUMOR CELL;

ADENOCARCINOMA; BIOPSY, FINE-NEEDLE; BREAST NEOPLASMS; CELL NUCLEUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; RECEPTORS, ESTROGEN; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL; VAGINAL SMEARS;

EID: 0344305611     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.10348     Document Type: Article

References (28)

1. Chevallier B, Heintzmann F, Mosseri V, et al. Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis. Cancer 1988;62:2517-2524.
2. Knight WA, Livingston RB, Gregory EJ, McGuire WL. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 1977;37:4667-4671.
3. McGuire WL. Steroid hormone receptors in breast cancer treatment strategy. Recent Prog Horm Res 1980;36:135-156.
4. Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999;17:1474-1481.
5. Allred D, Bustamante MA, Daniel CO, Gaskill HV, Cruz AB Jr. Immunohistochemical analysis of estrogen receptors in human breast carcinomas. Evaluation of 130 cases and a review of the literature regarding concordance with the biochemical method and clinical relevance. Arch Surg 1990;125:107-113.
6. Wilbur DC, Willis J, Mooney RA, Fallon MA, Moynes R, di Sant'Agnese PA. Estrogen and progesterone receptor detection in archival formalin-fixed, paraffin-embedded tissue from breast carcinoma: a comparison of immunohistochemistry with the dextran-coated charcoal assay. Mod Pathol 1992;5:79-84.
7. Zafrani B, Aubriot MH, Mouret E, et al. High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases. Histopathology 2000;37:536-545.
8. Shintaku IP, Said JW. Detection of estrogen receptors with monoclonal antibodies in routinely processed formalin-fixed paraffin sections of breast carcinoma. Am J Clin Pathol 1987;87:161-167.
9. McCarty KS Jr, Szabo E, Flowers JL, et al. Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res 1986;46(Suppl):4244s-4248s.
10. Hudock JA, Hanau CA, Christen R, Bibbo M. Expression of estrogen and progesterone receptor s in cytologic specimens using various fixatives. Diagn Cytopathol 1996;15:78-83.
11. Nizzoli R, Bozzetti C, Naldi N, et al. Comparison of the results of immunocytochemical assays for biologic variables on preoperative fine-needle aspiarates and on surgical specimens of primary breast carcinomas. Cancer 2000;90:61-66.
12. Frigo B, Pilotti S, Zurrida S, Ermellino L, Manzari A, Rilke F. Analysis of estrogen and progesterone receptors on preoperative fine-needle aspirates. Breast Cancer Res Treat 1995;33:179-184.
13. Reiner A, Spona J, Reiner G, et al. Estrogen receptor analysis on biopsies and fine needle aspirates from human breast carcinoma. Am J Pathol 1986;125:443-449.
14. Katz RL, Patel S, Sneige N, et al. Comparison of immunocytochemical and biochemical assays for estrogen receptor in fine needle aspirates and histologic sections from breast carcinomas. Breast Cancer Res Treat 1990;15:191-203.
15. Masood S. Immunocytochemical localization of estrogen and progesterone receptors in imprint preparations of breast carcinomas. Cancer 1992;70:2109-2114.
16. Nizzoli R, Bozzetti C, Savoldi L, et al. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients. Acta Cytol 1994;38:933-938.
17. Marchetti E, Bagni A, Querzoli P, et al. Immunocytochemical detection of estrogen receptors by staining with monoclonal antibodies on cytologic specimens of human breast cancer. Acta Cytol 1988;32:829-834.
18. Schmitt FC, Bento MJ, Amendoeira I. Estimation of estrogen receptor content in fine-needle aspirates from breast cancer using the monoclonal antibody 1D5 and microwave oven processing: correlation with paraffin embedded and frozen sections determinations. Diagn Cytopathol 1995;13:347-351.
19. Koyatsu J, Ishi K, Suzuki F, Saito A, Kina K, Okazaki T. Usefulness of estrogen receptor detection using archival Papanicolaou stained smears. Acta Cytol 1999;43:825-829.
20. Masood S. Use of monoclonal antibody for assessment of estrogen receptor content in fine needle aspiration biopsy specimen from patients with breast cancer. Arch Pathol Lab Med 1989;113:26-30.
21. Kuenen-Boumeester V, Timmermans AM, DeBruijn EMCA, Henzen-Logmans SC. Immunocytochemical detection of prognostic markers in breast cancer, technical consideration. Cytopathology 1999;10:308-316.
22. Bozzetti C, Nizzoli R, Naldi N, et al. Fine needle aspiration technique for the concurrent immunocytochemical evaluation of multiple biologic parameters in primary breast carcinoma. Breast Cancer Res Treat 1994;32:221-228.
23. Makris A, Allred DC, Powles TJ, et al. Cytological evaluation of biological prognostic markers from primary breast carcinomas. Breast Cancer Res Treat 1997;44:65-74.
24. Nizzoli R, Bozzetti C, Naldi N, et al. Comparison of the results of immunocytochemical assays for biologic variables on preoperative fine needle aspirates and on surgical specimens of primary breast carcinoma. Cancer Cytopathol 2000;90:61-66.
25. Skoog L, Humla S, Isaksson, Tani E. Immunocytochemical analysis of receptors for estrogen and progesterone in fine-needle aspirates from human breast carcinomas. Diagn Cytopathol 1990;6:95-98.
26. Deligeorgi-Politi H, Bartziota EV, Mavrogeorgis A, Sekeris CE. Determination of estrogen receptors in cytologic imprints of breast cancers using immunocytochemical methods. Acta Cytol 1990;34:881-884.
27. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:557-580.
28. Dabbs DJ, Abendroth CS, Grenko RT, Wang X, Radcliffe GE. Immunocytochemistry on the thin prep processor. Diagn Cytopathol 1997;17:338-392.